| Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia JA Fraietta, SF Lacey, EJ Orlando, I Pruteanu-Malinici, M Gohil, S Lundh, ... Nature medicine 24 (5), 563-571, 2018 | 1578 | 2018 |
| CRISPR-engineered T cells in patients with refractory cancer EA Stadtmauer, JA Fraietta, MM Davis, AD Cohen, KL Weber, E Lancaster, ... Science 367 (6481), eaba7365, 2020 | 1344 | 2020 |
| NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma AP Rapoport, EA Stadtmauer, GK Binder-Scholl, O Goloubeva, DT Vogl, ... Nature medicine 21 (8), 914-921, 2015 | 1034 | 2015 |
| B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma AD Cohen, AL Garfall, EA Stadtmauer, JJ Melenhorst, SF Lacey, ... The Journal of clinical investigation 129 (6), 2210-2221, 2019 | 738 | 2019 |
| Decade-long leukaemia remissions with persistence of CD4+ CAR T cells JJ Melenhorst, GM Chen, M Wang, DL Porter, C Chen, MKA Collins, ... Nature 602 (7897), 503-509, 2022 | 687 | 2022 |
| PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial V Narayan, JS Barber-Rotenberg, IY Jung, SF Lacey, AJ Rech, MM Davis, ... Nature medicine 28 (4), 724-734, 2022 | 321 | 2022 |
| Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display AS Payne, K Ishii, S Kacir, C Lin, H Li, Y Hanakawa, K Tsunoda, ... The Journal of clinical investigation 115 (4), 888-899, 2005 | 250 | 2005 |
| Inappropriate testing for diarrheal diseases in the hospital DL Siegel, PH Edelstein, I Nachamkin Jama 263 (7), 979-982, 1990 | 245 | 1990 |
| Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma AL Garfall, EA Stadtmauer, WT Hwang, SF Lacey, JJ Melenhorst, ... JCI insight 3 (8), e120505, 2018 | 219 | 2018 |
| Impact of pre-existing immunity on gene transfer to nonhuman primate liver with adeno-associated virus 8 vectors L Wang, R Calcedo, P Bell, J Lin, RL Grant, DL Siegel, JM Wilson Human gene therapy 22 (11), 1389-1401, 2011 | 206 | 2011 |
| Genetic analysis of autoantibodies in idiopathic thrombocytopenic purpura reveals evidence of clonal expansion and somatic mutation JH Roark, JB Bussel, DB Cines, DL Siegel Blood, The Journal of the American Society of Hematology 100 (4), 1388-1398, 2002 | 196 | 2002 |
| T-cell phenotypes associated with effective CAR T-cell therapy in postinduction vs relapsed multiple myeloma AL Garfall, EK Dancy, AD Cohen, WT Hwang, JA Fraietta, MM Davis, ... Blood advances 3 (19), 2812-2815, 2019 | 195 | 2019 |
| Bispecific and split CAR T cells targeting CD13 and TIM3 eradicate acute myeloid leukemia X He, Z Feng, J Ma, S Ling, Y Cao, B Gurung, Y Wu, BW Katona, ... Blood, The Journal of the American Society of Hematology 135 (10), 713-723, 2020 | 177 | 2020 |
| Isolation of cell surface-specific human monoclonal antibodies using phage display and magnetically-activated cell sorting: applications in immunohematology DL Siegel, TY Chang, SL Russell, VY Bunya Journal of immunological methods 206 (1-2), 73-85, 1997 | 165 | 1997 |
| Recombinant monoclonal antibody technology DL Siegel Transfusion clinique et biologique 9 (1), 15-22, 2002 | 158 | 2002 |
| Partial purification and characterization of an actin-bundling protein, band 4.9, from human erythrocytes. DL Siegel, D Branton Journal of Cell Biology 100 (3), 775-785, 1985 | 158 | 1985 |
| Characterization of a murine monoclonal antibody that mimics heparin-induced thrombocytopenia antibodies GM Arepally, S Kamei, KS Park, K Kamei, ZQ Li, W Liu, DL Siegel, ... Blood, The Journal of the American Society of Hematology 95 (5), 1533-1540, 2000 | 152 | 2000 |
| Humanized CD19-targeted chimeric antigen receptor (CAR) T cells in CAR-naive and CAR-exposed children and young adults with relapsed or refractory acute lymphoblastic leukemia RM Myers, Y Li, A Barz Leahy, DM Barrett, DT Teachey, C Callahan, ... Journal of Clinical Oncology 39 (27), 3044-3055, 2021 | 146 | 2021 |
| Phage antibody display libraries: a powerful antibody discovery platform for immunotherapy A Zhao, MR Tohidkia, DL Siegel, G Coukos, Y Omidi Critical reviews in biotechnology 36 (2), 276-289, 2016 | 132 | 2016 |
| Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study JH Beigel, P Tebas, MC Elie-Turenne, E Bajwa, TE Bell, CB Cairns, ... The Lancet Respiratory Medicine 5 (6), 500-511, 2017 | 124 | 2017 |
